LGB Corporate Finance is pleased to announce that it has advised RHEON LABS Ltd on its oversubscribed £7 million Series A equity capital raise. The transaction was achieved by way of a private placement. Read more
LGB has made arrangements for the settlement of an issue of MTNs by SRT Marine Systems plc through Euroclear’s CREST settlement system.Read more
SCISYS Group plc has received a cash offer from Canadian company CGI Inc. The offer price of 254.15p represents a 24.6% premium to yesterday’s closing price and values SCISYS at c£78.9m. Read more
Scancell (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer, has raised £3.89m by the issue of new ordinary shares to Vulpes Life Sciences Fund.Read more
Ivan Sedgwick, Investments Director at LGB & Co. Limited, wrote an article for Growth Business on why AIM needs to attract institutional interest and improve transparency and governance.
Simone Westerhuis, Director of LGB Investments, discusses the fixed income terrain and how different sectors will fare in uncertain economic times.
Sema Lease UK Limited, the leading UK provider of short- to medium-term vehicle rental, issued notes from its existing £25 million MTN Programme. The notes have 1, 2, and 3 year maturities paying 6.0%, 7.0%, and 8.0% interest p.a. Read more
Interrad Medical's subcutaneous catheter securement device, SecurAcath, is rapidly becoming the standard of care in hospitals of NHS England and in leading hospitals around the world.
SRT, the global provider of maritime surveillance and vessel tracking systems, required certainty of funding to progress with a large systems project. SRT is a regular issuer of loan notes through its existing £10 million MTN Programme. Read more
August Equity has announced that it has funded the management buy-out of Hallmarq Veterinary Imaging, a global specialist in MRI scanning of horses and companion animals.Read more
Happy New Year to all! A number of experts, including our own Simone Westerhuis, gave their new years financial resolutions to the Financial Times - what are yours?